Home/Filings/4/0001415889-23-008228
4//SEC Filing

GRAHAM RICHARD A 4

Accession 0001415889-23-008228

CIK 0001583107other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 6:17 PM ET

Size

4.7 KB

Accession

0001415889-23-008228

Insider Transaction Report

Form 4
Period: 2023-05-15
GRAHAM RICHARD A
SVP, Development
Transactions
  • Sale

    Ordinary Shares

    2023-05-15$11.26/sh2,322$26,146367,172 total
Footnotes (1)
  • [F1]This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22.

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001820036

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 6:17 PM ET
Size
4.7 KB